Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Short Interest Update

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 60,200 shares, an increase of 29.2% from the September 30th total of 46,600 shares. Based on an average daily volume of 3,380,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 2.5% of the shares of the company are short sold.

Catheter Precision Stock Up 5.2 %

Shares of NYSEAMERICAN:VTAK traded up $0.03 during midday trading on Tuesday, reaching $0.59. 553,316 shares of the company’s stock traded hands, compared to its average volume of 1,077,358. Catheter Precision has a one year low of $0.31 and a one year high of $8.40.

Catheter Precision (NYSEAMERICAN:VTAK) last posted its earnings results on Wednesday, August 14th. The company reported ($5.57) earnings per share for the quarter. Catheter Precision had a negative net margin of 2,176.83% and a negative return on equity of 50.02%. The firm had revenue of $0.09 million during the quarter. On average, analysts forecast that Catheter Precision will post -8.7 EPS for the current year.

About Catheter Precision

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.